Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

InSite Vision researchers prepare ophthalmic compositions of oxazolidinones

April 26, 2001

Lumigan introduced following mid-March approval by FDA

April 26, 2001

New PKC activators useful for ocular hypertension, glaucoma, etc.

April 4, 2001

Travatan launch quickly follows first approval in U.S.

April 4, 2001

Lumigan: a potent, long-acting and safe new IOP-lowering drug

April 2, 2001

Recently approved IOP-lowering prostaglandin highlighted at Prague glaucoma meeting

March 29, 2001

ROCK inhibitors investigated for potential as antiglaucoma drugs

March 29, 2001

Expanded use of Visudyne approved in E.U.

March 27, 2001

Iomed and Santen to develop treatment of posterior eye diseases

March 26, 2001

Two new antiglaucoma drugs approved by FDA

March 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...